StockData
Adagene Inc. logo

Adagene Inc. (ADAG) stock

ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 5/30
$1.82+0.34 (+22.97%)

Close on Nov 18, 2026Market cap $107.80MP/E –Yield –

Adagene operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$21.44M. The highest annual figure on record is -$17.33M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.44M–
FY2024Dec 31, 2024-$35.95M–
FY2023Dec 31, 2023-$23.72M–
FY2022Dec 31, 2022-$83.92M–
FY2021Dec 31, 2021-$72.36M–
FY2020Dec 31, 2020-$43.15M–
FY2019Dec 31, 2019-$19.17M–
FY2018Dec 31, 2018-$17.33M–

More Adagene figures

See a number that looks wrong?